Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) traded up 3.9% during mid-day trading on Tuesday . The company traded as high as $11.14 and last traded at $11.2450. Approximately 29,026 shares traded hands during trading, a decline of 94% from the average session volume of 448,545 shares. The stock had previously closed at $10.82.

Analysts Set New Price Targets

• Falling Fast, Rising Soon? 3 Stocks With Upside Ahead

Several research firms have weighed in on ARDT. The Goldman Sachs Group reaffirmed a "neutral" rating and set a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th. Zacks Research lowered Ardent Health from a "hold" rating to a "strong sell" rating in a research report on Thursday, August 6th. Guggenheim raised their price target on Ardent Health from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. Weiss Ratings cut shares of Ardent Health from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 11th. Finally, Wall Street Zen cut shares of Ardent Health from a "buy" rating to a "hold" rating in a research report on Sunday, July 12th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, Ardent Health currently has an average rating of "Hold" and an average price target of $13.05.

Check Out Our Latest Stock Analysis on ARDT

Ardent Health Price Performance

The stock's 50 day moving average price is $10.59 and its two-hundred day moving average price is $9.78. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of 20.13, a P/E/G ratio of 3.07 and a beta of 0.70. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Analysts anticipate that Ardent Health, Inc. will post 0.97 EPS for the current fiscal year.

Insider Buying and Selling at Ardent Health

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of the business's stock in a transaction on Friday, June 5th. The shares were bought at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.90% of the company's stock.

Institutional Investors Weigh In On Ardent Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Corient Private Wealth LP acquired a new stake in Ardent Health in the 2nd quarter valued at approximately $159,000. AXQ Capital LP boosted its position in shares of Ardent Health by 69.3% during the second quarter. AXQ Capital LP now owns 25,045 shares of the company's stock valued at $246,000 after purchasing an additional 10,249 shares in the last quarter. Hsbc Holdings PLC lifted its position in Ardent Health by 166.8% in the 2nd quarter. Hsbc Holdings PLC now owns 55,280 shares of the company's stock valued at $543,000 after acquiring an additional 34,557 shares in the last quarter. Empowered Funds LLC bought a new position in Ardent Health in the second quarter worth approximately $5,425,000. Finally, Bank of America Corp DE purchased a new position in shares of Ardent Health in the second quarter worth $3,840,000.

About Ardent Health

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

See Also

• Five stocks we like better than Ardent Health
• Dutch Bros Sell-Off Creates a Growth Opportunity
• NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
• Is Abercrombie & Fitch's Hot Streak Just Getting Started?
• Medtronic’s Stars Are Aligning for a Price Recovery

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ardent Health Right Now?

Before you consider Ardent Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.

While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here